West Pharmaceutical Services Other Non-Current Liabilities 2010-2024 | WST

West Pharmaceutical Services other non-current liabilities from 2010 to 2024. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • West Pharmaceutical Services other non-current liabilities for the quarter ending December 31, 2024 were $0.062B, a 6.32% increase year-over-year.
  • West Pharmaceutical Services other non-current liabilities for 2024 were $0.062B, a 6.32% increase from 2023.
  • West Pharmaceutical Services other non-current liabilities for 2023 were $0.059B, a 13.37% increase from 2022.
  • West Pharmaceutical Services other non-current liabilities for 2022 were $0.052B, a 35.08% increase from 2021.
West Pharmaceutical Services Annual Other Non-Current Liabilities
(Millions of US $)
2024 $62
2023 $59
2022 $52
2021 $38
2020 $32
2019 $23
2018 $34
2017 $43
2016 $47
2015 $
2014 $53
2013 $55
2012 $38
2011 $54
2010 $34
2009 $34
West Pharmaceutical Services Quarterly Other Non-Current Liabilities
(Millions of US $)
2024-12-31 $62
2024-09-30 $67
2024-06-30 $63
2024-03-31 $58
2023-12-31 $59
2023-09-30 $55
2023-06-30 $55
2023-03-31 $56
2022-12-31 $52
2022-09-30 $34
2022-06-30 $35
2022-03-31 $38
2021-12-31 $38
2021-09-30 $28
2021-06-30 $30
2021-03-31 $28
2020-12-31 $32
2020-09-30 $47
2020-06-30 $43
2020-03-31 $40
2019-12-31 $23
2019-09-30 $36
2019-06-30 $35
2019-03-31 $34
2018-12-31 $34
2018-09-30 $44
2018-06-30 $42
2018-03-31 $36
2017-12-31 $43
2017-09-30 $46
2017-06-30 $47
2017-03-31 $47
2016-12-31 $47
2016-09-30 $50
2016-06-30 $52
2016-03-31 $50
2015-12-31
2015-09-30 $49
2015-06-30 $50
2015-03-31 $50
2014-12-31 $53
2014-09-30 $52
2014-06-30 $53
2014-03-31 $53
2013-12-31 $55
2013-09-30 $54
2013-06-30 $58
2013-03-31 $40
2012-12-31 $38
2012-09-30 $38
2012-06-30 $35
2012-03-31 $33
2011-12-31 $54
2011-09-30 $51
2011-06-30 $46
2011-03-31 $43
2010-12-31 $34
2010-09-30 $34
2010-06-30 $36
2010-03-31 $34
2009-12-31 $34
2009-09-30 $35
2009-06-30 $31
2009-03-31 $33
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $15.984B $2.893B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.918B 20.77
Becton Dickinson (BDX) United States $66.130B 16.56
Cardinal Health (CAH) United States $30.812B 16.50
Straumann Holding AG (SAUHY) Switzerland $22.515B 0.00
Labcorp (LH) United States $21.029B 17.26
Cooper (COO) United States $17.974B 24.34
Align Technology (ALGN) United States $14.238B 27.05
Henry Schein (HSIC) United States $9.680B 18.44
Merit Medical Systems (MMSI) United States $6.033B 30.81
DENTSPLY SIRONA (XRAY) United States $3.787B 10.30
Patterson (PDCO) United States $2.744B 14.66
CONMED (CNMD) United States $1.915B 14.90
STAAR Surgical (STAA) United States $0.800B 0.00
Lifevantage (LFVN) United States $0.211B 23.38
Pro-Dex (PDEX) United States $0.108B 16.47